• Citer

Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir

par Schreiber, Jonas ;McNally, John;Chodavarapu, Krishna;Svarovskaia, Evguenia;Moreno, Christophe
Référence Hepatology, 64, 3, page (983-985)
Publication Publié, 2016

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

During a phase 3 study evaluating the combination of sofosbuvir-velpatasvir for 12 weeks in patients with genotype 1, 2, 4, 5, and 6 hepatitis C virus (HCV) infection, we enrolled a patient who was subsequently found to be infected with genotype 7 HCV. This patient tolerated the study regimen well and achieved sustained virological response 12 weeks after treatment (SVR12). (Hepatology 2016;64:983-985).